Alcon (ALC) Net Income towards Common Stockholders Growth (1y) (2010 - 2025)
Powered by 
Analysis
Alcon (ALC) Net Income towards Common Stockholders Growth (1y) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | -27.18% |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 38.54% |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 0.98% |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | - |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | 12.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.41% |
| Sep 30, 2025 | -1.99% |
| Jun 30, 2025 | -21.08% |
| Dec 31, 2024 | 494.51% |
| Sep 30, 2024 | 47.79% |
| Jun 30, 2024 | -13.23% |
| Mar 31, 2024 | 53.57% |
| Dec 31, 2023 | -360.00% |
| Sep 30, 2023 | 52.81% |
| Jun 30, 2023 | 76.03% |
| Mar 31, 2023 | 8.62% |
| Dec 31, 2022 | -75.52% |
| Sep 30, 2022 | 470.83% |
| Jun 30, 2022 | -36.80% |
| Mar 31, 2022 | 73.13% |
| Dec 31, 2021 | -96.09% |
| Sep 30, 2021 | 74.60% |
| Jun 30, 2021 | 139.69% |
| Mar 31, 2021 | 265.43% |
| Dec 31, 2020 | 23.69% |